ABVX (Abivax) Forward P/E Multiple
ABIVAX is developing breakthrough treatments for intestinal inflammation using its proprietary obefazimod. GURU.Markets analytics include a forward P/E based on company analyst estimates, where the value 0.00 corresponds to the current metric. Despite global disruptions in biocomponent logistics, the humanitarian status of developments in Western countries minimizes sanction risks and ensures the stability of the operating model.
Analytical breakdowns for ABIVAX
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ABVX - Company Net Income|Projected Future Earnings ABIVAX|ABVX - Business Payback Period|Projected Price to Earnings ABIVAX|ABVX - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Abivax Pharma|ABVX - Operating profit EBITDA|Net earnings per share for the last 12 months Abivax|ABVX - Earnings per share for the last 12 months|Quarterly EPS earnings growth abivax.com|ABVX - Earnings growth in current year|Earnings growth forecast for next year ABIVAX
- total revenue and sales volume data:
Summary company analytics:Abivax
The forward P/E of ABIVAX (ABVX) reflects the market value of the stock relative to expected annual net income, allowing investors to assess the premium paid for future growth. The forward P/E trend demonstrates how the market currently prices in the potential for ABIVAX (ABVX) to commercialize drugs for inflammatory bowel disease amid high unmet demand.
Competitors of ABIVAX (ABVX)
Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ADMA (admabiologics.com)|Market Cap to Projected Earnings protagonist-inc.com (PTGX)|IMVT - Future Price to Earnings|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Projected Price to Earnings|Grifols Biemat (GRFS) - Future Price to Earnings|Projected Price to Earnings Adaptive Biotechnologies|Projected Price to Earnings CLDX|Forward P/E Multiple auriniapharma.com|Future Price to Earnings BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Projected Price to Earnings Ratio|AbCellera Biologics - Forward P/E Multiple|tourmalinebio.com - Market Cap to Future Earnings Ratio|Precigen (PGEN) - Future Price to Earnings|Pharming Group - Future Price to Earnings Multiple|Future Price to Earnings Nektar Therapeutics Inc|UPB (Upstream Pharma) - Market Cap to Future Earnings Ratio|Forward P/E Multiple ZBIO|Forward P/E Multiple immunome.com (IMNM)|Forward P/E Multiple GOSS (gossamerbio.com)|Market Cap to Projected Earnings KalVista Pharma (KALV)|SEPN - Future Price to Earnings|Market Cap to Projected Earnings Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Projected Price to Earnings|Price to Expected Earnings Ratio RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Forward P/E Multiple|ATXS (Astria Therapeutics, Inc.) - Market Cap to Future Earnings Ratio|Future Price to Earnings engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Future Price to Earnings Multiple|Aerovate Therapeutics - Projected Price to Earnings|Future Price to Earnings Multiple ACRS|Kyverna Therapeutics, Inc - Forward P/E Multiple|Price to Expected Earnings Ratio TLSA|CABA: Forward P/E Multiple|Projected Price to Earnings Ventyx Bio|Future Price to Earnings Theratechnologies, Inc.|Projected Price to Earnings Ratio Avalo Therapeutics AVTX|Forward P/E Multiple ELDN|AGEN (Agenus, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Projected Price to Earnings Ratio|ATYR: Projected Price to Earnings|adagene.com (ADAG) - Projected Price to Earnings|Ikena Oncology (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs, Inc.|Future Price to Earnings equilliumbio.com|Projected Price to Earnings connectbiopharm.com (CNTB)|Forward P/E Multiple IMUX|Market Cap to Projected Earnings Atara Bio|Future Price to Earnings InflaRx N.V. IFRX|X4 Pharmaceuticals - Future Price to Earnings|ACET: Projected Price to Earnings|Future Price to Earnings Multiple CELU (celularity.com)|INMB: Forward P/E Multiple|BRNS: Market Cap to Future Earnings Ratio|KZR (Kezar Life Sciences, Inc.) - Forward P/E Multiple|SAB Biotherapeutics Inc. (SABS) - Market Cap to Projected Earnings|Forward P/E Multiple AKTX|Future Price to Earnings ENLV (Enlivex Therapeutics Ltd)|Future Price to Earnings Q32 Bio Inc. QTTB|GOVX - Projected Price to Earnings|EDSA - Future Price to Earnings|Projected Price to Earnings Ratio iBio|CARM: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple
